Search results: International
News
University of Tampa students helping raise awareness and funds for testicular cancer
A new imaging technique could potentially help thousands of men avoid invasive tests to check if they have prostate cancer, according to Movember-funded research.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
5 men’s health projects across Australia, the UK, and Ireland will receive a total of $2.38M AUD in funding over the next two years.
What if you were diagnosed with testicular cancer at 17 years old? Hear from cancer survivor Norman about his cancer treatment and recovery.
A new prostate cancer treatment has shown similar survival rates to chemotherapy, but with fewer side effects.
What if you were diagnosed with testicular cancer at 17 years old? Hear from cancer survivor Norman about his cancer treatment and recovery.
What if you were diagnosed with testicular cancer at 17 years old? Hear from cancer survivor Norman about his cancer treatment and recovery.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
5 men’s health projects across Australia, the UK, and Ireland will receive a total of $2.38M AUD in funding over the next two years.
Mo Bro Ciarán takes a seat in the barber chair to share his story.
And the moment you've all been waiting for... here are the legendary winners of the annual event...
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A new prostate cancer treatment has shown similar survival rates to chemotherapy, but with fewer side effects.
Movember is thrilled to announce a partnership with the University of Adelaide, to create a transformative database that will help researchers develop strategies for clinicians to personalise decisions about prostate cancer care.
(1).png)
